Jack Meehan
Stock Analyst at Barclays
(3.05)
# 1,384
Out of 5,102 analysts
137
Total ratings
69.51%
Success rate
21.33%
Average return
Main Sectors:
Stocks Rated by Jack Meehan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Equal-Weight | $275 → $290 | $264.73 | +9.55% | 17 | Oct 2, 2025 | |
| A Agilent Technologies | Maintains: Underweight | $120 → $125 | $142.87 | -12.51% | 20 | Feb 28, 2024 | |
| WAT Waters | Maintains: Equal-Weight | $275 → $288 | $392.21 | -26.57% | 10 | Aug 3, 2023 | |
| AVTR Avantor | Initiates: Overweight | $33 | $11.47 | +187.71% | 3 | Mar 3, 2021 | |
| ILMN Illumina | Initiates: Underweight | $325 | $136.44 | +138.20% | 8 | Mar 3, 2021 | |
| INMD InMode | Maintains: Overweight | $18 → $19 | $14.45 | +31.49% | 3 | Aug 17, 2020 | |
| DGX Quest Diagnostics | Maintains: Equal-Weight | $93 → $99 | $181.57 | -45.48% | 7 | Apr 23, 2020 | |
| ICLR ICON Public Limited Company | Maintains: Overweight | $170 → $180 | $189.93 | -5.23% | 2 | Apr 23, 2020 | |
| MYGN Myriad Genetics | Maintains: Underweight | $14 → $10 | $7.30 | +36.99% | 8 | Mar 26, 2020 | |
| IQV IQVIA Holdings | Maintains: Overweight | $192 → $166 | $225.98 | -26.54% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $43 | $74.83 | -42.54% | 9 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $170 → $154 | $194.43 | -20.79% | 7 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $313.97 | +36.96% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $318.34 | +35.08% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $29.66 | - | 10 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $52 → $48 | $46.37 | +3.52% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $720 → $680 | $1,421.58 | -52.17% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $30 | $79.55 | -62.29% | 3 | Oct 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $295 → $300 | $578.90 | -48.18% | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $40 | $1.24 | +3,116.73% | 1 | Dec 11, 2017 |
Labcorp Holdings
Oct 2, 2025
Maintains: Equal-Weight
Price Target: $275 → $290
Current: $264.73
Upside: +9.55%
Agilent Technologies
Feb 28, 2024
Maintains: Underweight
Price Target: $120 → $125
Current: $142.87
Upside: -12.51%
Waters
Aug 3, 2023
Maintains: Equal-Weight
Price Target: $275 → $288
Current: $392.21
Upside: -26.57%
Avantor
Mar 3, 2021
Initiates: Overweight
Price Target: $33
Current: $11.47
Upside: +187.71%
Illumina
Mar 3, 2021
Initiates: Underweight
Price Target: $325
Current: $136.44
Upside: +138.20%
InMode
Aug 17, 2020
Maintains: Overweight
Price Target: $18 → $19
Current: $14.45
Upside: +31.49%
Quest Diagnostics
Apr 23, 2020
Maintains: Equal-Weight
Price Target: $93 → $99
Current: $181.57
Upside: -45.48%
ICON Public Limited Company
Apr 23, 2020
Maintains: Overweight
Price Target: $170 → $180
Current: $189.93
Upside: -5.23%
Myriad Genetics
Mar 26, 2020
Maintains: Underweight
Price Target: $14 → $10
Current: $7.30
Upside: +36.99%
IQVIA Holdings
Mar 26, 2020
Maintains: Overweight
Price Target: $192 → $166
Current: $225.98
Upside: -26.54%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $51 → $43
Current: $74.83
Upside: -42.54%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $170 → $154
Current: $194.43
Upside: -20.79%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $313.97
Upside: +36.96%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $318.34
Upside: +35.08%
Mar 26, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $29.66
Upside: -
Mar 26, 2020
Upgrades: Overweight
Price Target: $52 → $48
Current: $46.37
Upside: +3.52%
Mar 26, 2020
Upgrades: Equal-Weight
Price Target: $720 → $680
Current: $1,421.58
Upside: -52.17%
Oct 2, 2019
Maintains: Underweight
Price Target: $28 → $30
Current: $79.55
Upside: -62.29%
Mar 18, 2019
Maintains: Overweight
Price Target: $295 → $300
Current: $578.90
Upside: -48.18%
Dec 11, 2017
Initiates: Equal-Weight
Price Target: $40
Current: $1.24
Upside: +3,116.73%